|1.||Molkentin, Jeffery D: 9 articles (10/2012 - 03/2005)|
|2.||Ovize, Michel: 3 articles (01/2015 - 07/2013)|
|3.||Belaidi, Elise: 3 articles (10/2013 - 04/2013)|
|4.||Du, Heng: 3 articles (03/2011 - 10/2008)|
|5.||Bernardi, Paolo: 3 articles (01/2010 - 05/2007)|
|6.||Baines, Christopher P: 3 articles (04/2008 - 03/2005)|
|7.||Robbins, Jeffrey: 3 articles (04/2008 - 03/2005)|
|8.||Ward, B K: 3 articles (06/2001 - 01/2001)|
|9.||Ratajczak, T: 3 articles (06/2001 - 01/2001)|
|10.||Minchin, R F: 3 articles (06/2001 - 01/2001)|
01/01/2010 - "Knockdown of Cyclophilin D Gene by RNAi Protects Rat from Ischemia/ Reperfusion-Induced Renal Injury."
04/01/2008 - "Recently the role of cyclophilin D, a component of the mitochondrial membrane permeability transition pore, has been identified in cardiac-ischemia. "
10/01/2015 - "Mitochondrial Cyclophilin D as a Potential Therapeutic Target for Ischemia-Induced Facial Palsy in Rats."
09/01/2010 - "The cyclophilin D mitochondrial membrane permeability transition pore is critical in adult ischemia, whereas in neonatal hypoxic-ischemic (HI) brain injury, mitochondrial permeabilization appears to be primarily Bax-dependent. "
11/01/2011 - "Mitochondrial membrane potential (ΔΨm, JC-1) and MPT (calcein) were studied in cardiomyocytes from wild-type and cyclophilin D (CyD) KO mice refractory to MPT, submitted to simulated ischemia and 10 min reperfusion. "
|2.||Alzheimer Disease (Alzheimer's Disease)
10/01/2008 - "Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease."
09/21/2012 - "Therefore, inhibition of cyclophilin D might be a therapeutic strategy for Alzheimer's disease."
03/01/2011 - "Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model."
06/01/2014 - "Cyclophilin D (CypD) is a key mitochondrial target for amyloid-β-induced mitochondrial and synaptic dysfunction and is considered a potential drug target for Alzheimer's disease. "
02/01/2010 - "Cyclophilin D (Cyp D) is implicated in cell death pathway and blockade of Cyp D could be a potent therapeutic strategy for degenerative disorders such as Alzheimer's disease, ischemia, and multiple sclerosis, but physiological role of Cyp D remains elusive. "
05/01/2015 - "E2F1-regulated miR-30b suppresses Cyclophilin D and protects heart from ischemia/reperfusion injury and necrotic cell death."
10/01/2013 - "Accumulation of Ca(2+) into the mitochondrial matrix may activate the mitochondrial chaperone cyclophilin D (CypD) and trigger permeability transition pore opening, whose role in ischemia/reperfusion injury is well recognized. "
02/01/2012 - "Mitochondrial CyP-D (cyclophilin-D) catalyses formation of the PT (permeability transition) pore, a key lesion in the pathogenesis of I/R (ischaemia/reperfusion) injury. "
01/01/2015 - "Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspective."
11/24/2015 - "Accordingly, cyclophilin-D and mPTP were increased in heterozygous hearts, but genetic ablation of cyclophilin-D in these hearts significantly alleviated their susceptibility to ischemia/reperfusion injury. "
05/01/2009 - "Mechanistic study showed that HNK caused cancer cell death by disruption of mitochondrial transmembrane potential and was correlated with cyclophilin D (CypD) expression. "
05/19/2006 - "It has been reported that cyclophilin D overexpression suppresses apoptosis in cancer cells. "
01/01/2004 - "Importantly, cyclophilin D is specifically up-regulated in human tumors of the breast, ovary, and uterus, suggesting that inhibition of the PT-pore via up-regulation of cyclophilin D plays a role in tumorigenesis."
05/01/2010 - "It was recently described as a component of a mitochondrial pathway selectively up-regulated in tumor cells which antagonizes the proapoptotic activity of cyclophilin D, a mitochondrial permeability transition pore regulator, and is responsible for the maintenance of mitochondrial integrity, thus favoring cell survival. "
01/12/2010 - "Thus, in tumor cells mitochondrial ERK activation desensitizes the PTP through a signaling axis that involves GSK-3 and cyclophilin D, a finding that provides a mechanistic basis for increased resistance to apoptosis of neoplastic cells."
|1.||mitochondrial permeability transition pore
|3.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|5.||Reactive Oxygen Species (Oxygen Radicals)
|8.||Mitochondrial Proteins (Mitochondrial Protein)
|10.||Amyloid (Amyloid Fibrils)